Robert Wellman, MS

Wellman_Robert_D_205x293.jpg

“Being part of Kaiser Permanente research teams gives me a chance to develop cutting-edge biostatistical methods while contributing to health care research with a national impact.”

Robert Wellman, MS

Principal Collaborative Biostatistician, Kaiser Permanente Washington Health Research Institute

Biography

A graduate of the University of Washington (UW) biostatistics program, Robert Wellman, MS, joined the Kaiser Permanente Washington Health Research Institute (KPWHRI) Biostatistics Unit in 2009. His work spans a diverse collection of topics including mental health, pharmacoepidemiology, postmarketing drug safety surveillance, obesity, diagnostic test accuracy, back pain, and breast cancer. Prior to this, he spent 5 years in the Biostatistics Core at the UW Center for AIDS Research.

Research interests and experience

  • Biostatistics

    Causal inference; longitudinal data; diagnostic and screening test accuracy; clinical trials; survival analysis: rare disease outcomes; nonparametrics; missing data; electronic data; distributed data; statistical computing

    Vaccines & Infectious Diseases

    Biostatistics; HIV/AIDS; vaccine safety

    Complementary & Integrative Health

    Biostatistics; clinical trials; back pain

    Obesity

    Biostatistics; bariatric surgery

  • Cancer

    Biostatistics; breast cancer; effects of chemotherapy; accuracy of automated data; screening test accuracy; advanced imaging

    Medication Use & Patient Safety

    Biostatistics; pharmacoepidemiology; postmarketing drug safety surveillance; big data; electronic health record and claims data

    Mental Health

    Biostatistics; suicide risk prediction, machine learning

  •  
  •  

Recent publications

Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.  Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15. PubMed

Stekler JD, Wellman R, Holte S, Maenza J, Stevens CE, Corey L, Collier AC. Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group.  Int J STD AIDS. 2012;23(3):201-6. PubMed

Cook AJ, Tiwari RC, Wellman RD, Heckbert SR, Li L, Heagerty P, Marsh T, Nelson JC. Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot.  Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:72-81. doi: 10.1002/pds.2320. PubMed

Bowles EA, Wellman R, Delate T, Allen L, Feigelson HS, Yood MU, Davis R, Nekhlyudov L, McCarty C, Habel L, Magid D, Onitilo A, Freedman A, Wagner E. Cardiotoxic chemotherapy is associated with increased heart failure risk among women with breast cancer in the Cancer Research Network. Clin Med Res. 2011;9(3-4):148. PubMed

Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M, Nekhlyudov L, Goddard K, Davis R, McCarty C, Onitilo A, Feigelson H, Freml J, Wagner E. Validity of HMO administrative data for breast cancer chemotherapy exposure. Clin Med Res. 2011;9(3-4):146. PubMed

 

New findings

Suicide-risk-modeling-story_1col.jpg

Simpler models to identify suicide risk perform similarly to more complex ones

Models that are easier to explain, use could have better uptake in health care settings.

Research

Insomnia-phone-therapy-elderly-blog_1col.jpg

Phone therapy for insomnia shown to improve sleep

A study among KP members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.

healthy findings blog

Video-screen_grab-bariatric-young_couple-_1_column.jpg

Best weight-loss surgery for diabetes and severe obesity?

Watch video on latest results from PCORnet Bariatric Study. (Spoiler alert: Bypass, not sleeve.)